Literature DB >> 12695430

Medicine partnerships.

J Cramer1.   

Abstract

Partial medication compliance, where patients do not take enough of their prescribed medicine to achieve adequate outcomes, is common. Research using electronic monitoring to assess compliance has shown that people take approximately 75% of doses as prescribed, irrespective of the condition being treated or its severity. Erratic compliance often leads to discontinuation of therapy, as treatment is perceived to be ineffective. Compliance decreases as frequency of dosing increases. Inadequate compliance and treatment persistence results in poor outcomes, despite the best efforts of the medical team. It is important to develop and implement a strategy to improve compliance. Simple steps that can be taken include helping patients to select "cues" to remind them to take their tablets, use of dose reminder boxes, and visual feedback of compliance data from electronic monitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695430      PMCID: PMC1876290          DOI: 10.1136/heart.89.suppl_2.ii19

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

1.  A systematic review of the associations between dose regimens and medication compliance.

Authors:  A J Claxton; J Cramer; C Pierce
Journal:  Clin Ther       Date:  2001-08       Impact factor: 3.393

2.  Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence.

Authors:  J A Cramer
Journal:  Am J Manag Care       Date:  1998-11       Impact factor: 2.229

3.  Enhancing medication compliance for people with serious mental illness.

Authors:  J A Cramer; R Rosenheck
Journal:  J Nerv Ment Dis       Date:  1999-01       Impact factor: 2.254

4.  Compliance declines between clinic visits.

Authors:  J A Cramer; R D Scheyer; R H Mattson
Journal:  Arch Intern Med       Date:  1990-07

5.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

6.  Withdrawal of statins increases event rates in patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Christian W Hamm; Ulrich Laufs; Steven Snapinn; Michael Böhm; Harvey D White
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

7.  Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

Authors:  M Burnier; M P Schneider; A Chioléro; C L Stubi; H R Brunner
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

8.  A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy.

Authors:  Luca Degli Esposti; Ezio Degli Esposti; Giorgia Valpiani; Mirko Di Martino; Stefania Saragoni; Stefano Buda; Gianluca Baio; Alessandro Capone; Alessandra Sturani
Journal:  Clin Ther       Date:  2002-08       Impact factor: 3.393

9.  Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population.

Authors:  J K Jones; L Gorkin; J F Lian; J A Staffa; A P Fletcher
Journal:  BMJ       Date:  1995-07-29
  9 in total
  2 in total

1.  "I just take what I am given": adherence and resident involvement in decision making on medicines in nursing homes for older people: a qualitative survey.

Authors:  Carmel M Hughes; Roz Goldie
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

2.  Noncompliance in neurologic patients.

Authors:  David B Weiss; Thomas P Beresford; Robert M House
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.